Misitatug blivedotin
Based on 1 Customer Validation
Misitatug blivedotin (RC88) is an antibody-drug conjugate (ADC) targeting mesothelin (MSLN). Misitatug blivedotin is formed by conjugating the humanized anti-mesothelin monoclonal antibody Misitatug (HY-P990929) with the microtubule inhibitor Monomethyl auristatin E (MMAE) (HY-15162) via a cleavable linker. Misitatug blivedotin binds to mesothelin and exhibits dose‐dependent antitumor activity. Misitatug blivedotin can be used for the research of ovarian cancer, non-squamous non-small-cell lung carcinoma, cervical cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 95.45%
-
보관:Shipping with dry ice
-80°C, protect from light
Biological Activity
제품 설명
In Vitro
Misitatug blivedotin (RC88) effectively blocks CA125 from binding to MSLN[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Balb/c nude mice (female; ages 4–5 weeks; implanted subcutaneously with 3 million OVCAR3‐MSLN‐3# or H292‐MSLN‐9C8 cells for a xenograft model)[3]
-
Dosage:0.7 mg/kg; 0.75 mg/kg; 1.5 mg/kg; 2.1 mg/kg; 3 mg/kg
-
Administration:i.v.; Q1W × 1 or Q1W × 3
-
Result:Had moderate activity at 0.75 mg/kg with single dosing, but tumor volume was less than the initial volume of tumors treated at 2.1 mg/kg until 11 days after dosing.
Significantly reduced the tumors 7 days after the first dosing at 1.5 and 3 mg/kg with multiple dosing.
Fully regressed tumors at 3 mg/kg for 10 days and at 1.5 mg/kg for 17 days, but the tumor continued to grow after three administrations at 0.75 mg/kg.
Chemical Information
-
Appearance Liquid
-
Color Colorless to light yellow
-
SMILES
[Misitatug blivedotin]
-
Synonyms
RC88
-
선적
Shipping with dry ice.
-
보관
-80°C, protect from light
순도&문서
-
Data Sheet (274 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Misitatug blivedotin
- RC88
- RC 88
- RC-88
- Antibody-Drug Conjugates (ADCs)
- Mesothelin
- Antibody-Drug Conjugates
- ADC
- MSLN
- cynomolgus monkeys
- ocular toxicity
- mesothelin
- mice xenograft models
- non-squamous non-small-cell lung carcinoma
- ovarian cancer
- mesothelin-positive tumors
- mesothelin (MSLN)
- hematologic toxicity
- cervical cancer
- Inhibitor
- inhibitor
- inhibit